
RCM Technologies (RCMT) Stock Forecast & Price Target
RCM Technologies (RCMT) Analyst Ratings
Bulls say
RCM Technologies is supported by a high-margin, asset-light model that produced strong cash generation, with net cash from operations of $13.5M in the first half versus $8.8M a year ago and over 54% Y/Y operating cash flow growth in 1H26. Revenue momentum is broad-based, with 2Q26 revenue of $93.8M up 20.2% Y/Y, adjusted EBITDA of $9.3M versus $8.1M, and adjusted EPS of $0.82 versus $0.69, while Specialty Health Care delivered steadier, more consistent results. Engineering and Life Sciences/Data & Solutions should benefit from strong backlog and accelerating demand tied to grid modernization and data center development, while valuation remains attractive at 9.0x EV/EBITDA and 14.5x 2027 P/E relative to peers.
Bears say
RCM Technologies is facing a negative outlook because its apparent growth is still exposed to meaningful operational and cyclical risks, including acquisition integration, competition from larger firms, North American economic softness, and labor retention challenges. While 2Q26 revenue rose 20% y/y to $83.8M and gross profit increased to $24.1M, gross margin fell to 25.7% from 28.5% a year ago and adjusted EBITDA margin slipped to 10%, showing that higher subcontractor mix can dilute profitability. Its dependence on cyclical end markets, customer concentration, and exposure to regulatory and subcontractor-related risks make earnings quality vulnerable despite short-term revenue gains.
This aggregate rating is based on analysts' research of RCM Technologies and is not a guaranteed prediction by Public.com or investment advice.
RCM Technologies (RCMT) Analyst Forecast & Price Prediction
Start investing in RCM Technologies (RCMT)
Order type
Buy in
Order amount
Est. shares
0 shares